We are live on ! Find out more
CP

Catalys Pacific Portfolio holdings

AUM $229M
1-Year Est. Return 100.3%
This Fund
S&P 500
This Quarter Est. Return
+26.45%
1 Year Est. Return
+100.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$149M
AUM Growth
+$32.8M
Cap. Flow
+$2.98M
Cap. Flow %
2.01%
Top 10 Hldgs %
100%
Holding
2
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
MLYS icon
Mineralys Therapeutics
MLYS
+$2.98M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLYS icon
1
Mineralys Therapeutics
MLYS
$2.34B
$141M 95.08%
8,903,838
+259,259
+3% +$2.98M
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$679M
$7.32M 4.92%
1,167,114

Similar funds

Catalys Pacific's Q1 2025 Portfolio in Review

As of Q1 2025, Catalys Pacific held 2 positions worth $149M, up 28% from $116M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. Catalys Pacific opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Catalys Pacific added most to Mineralys Therapeutics in Q1 2025, an estimated $2.98M increase.
  • Catalys Pacific's ten largest holdings make up 100% of its $149M portfolio in Q1 2025.
  • Catalys Pacific opened 0 new positions and closed 0 in Q1 2025.
  • Catalys Pacific's portfolio value rose 28% quarter-over-quarter to $149M.

Based on Catalys Pacific's 13F filing for Q1 2025, filed 14 May 2025.